CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Histopathological signs and their relationships with survival in chronic allograft nephropathy

Author: 
Ali Abbas Ozdemir and Murat Altay
Subject Area: 
Health Sciences
Abstract: 

Aim: To investigate possible factors contributing to chronic allograft dysfunction (CAD), efficacy of histopathological evaluation in recipients with chronic allograft nephropathy (CAN), and determinative role of histopathological signs in graft survival. Methods: Data of the recipients who underwent renal transplantation (n=270) 10 years in our department were evaluated. The recipients were evaluated in 3 groups as normal allograft function (NAF) group (n=154) and CAD (n=64) and CAN (n=52) groups. Results: Regarding the allograft survival, the NAF group had the best allograft survival. The frequency of hepatitis C virus (HCV) positivity was significantly lower in the NAF group. Although not significant, the frequency of HCV differed between the CAN patients with and without glomerulopathy (34% and 23.5%, respectively). According to the 3-year allograft survival, graft loss was observed to be earlier in the patients with transplant glomerulopathy, without a significant difference. The frequency of proteinuria was higher in the CAD and CAN groups than in the NAF group and proteinuria was appeared firstly in the CAN group and then in the CAD and NAF groups. Fibrointimal thickening was present in 17 patients in the CAN group and the graft survival was observed to decrease with an increase in the fibrointimal thickening. In the CAD group, 30 patients had mild fibrosis and 20 had moderate/severe fibrosis. Tubulointerstitial fibrosis was more severe in the patients who received cyclosporine A. Conclusions: CAN after renal transplantation is frequently encountered and the risk of developing CAN increases in the long term after transplantation.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran